Market Insight Therapeutics |

Potential First-In-Class Antibody For Parkinson’s Disease Targeting The Prostaglandin Pathway

Jorge Dias

Director Antibody Discovery

Alchemab Therapeutics

13 August, 2026

Watch time: 16 Minutes

Highlights

Takeaways

PREMIUM CONTENT

Want that extra level of detail?
Subscribe and get access to full length presentations and write-ups giving you the insights to stay ahead of the curve.

Please note once we have received payment it can take 24 hours for your account to be updated to the premium access.

Upgrade

Full Video Transcript